CSIMarket Company Name, Ticker, Competitors, else..


Edoc Acquisition Corp   (ADOC)
Other Ticker:  
 

Edoc Acquisition Corp

ADOC's Fundamental analysis



Looking into Edoc Acquisition growth rates, revenue grew by 5229.43 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 2309

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -4.45 %



• More on ADOC's Growth


Edoc Acquisition
reported net loss of -8 millions in the past twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.52.


• More on ADOC's Valuation
 
 Total Debt (Millions $) 2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Edoc Acquisition
reported net loss of -8 millions in the past twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.52.